Global life sciences industry players see new opportunities in China, the world's second-largest pharmaceutical market, as the government pushes for innovation for a healthier country.
WuXi Biologics, a Wuxi-based global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, became the first biologics company in China to be approved by both the U.S. FDA and EMA.
Wuxi city in East China's Jiangsu province got the chance to promote itself as available for more cooperation all over the world during the Boao Forum for Asia on March 27.
Wuxi, the historical city with eye-catching scenery located in East China's Jiangsu province, is revving up development in innovative industries such as the internet of things and intelligent manufacturing, Mayor Huang Qin said during a media interview on the sidelines of the Boao Forum for Asia.
The forum, hosted by the Wuxi Municipal People's Association for Friendship with Foreign Countries, is part of the 2019 Wuxi International Cherry Blossom Festival, which has become not only a festival for cherry blossom admiring, but also a platform for boosting cooperation between Wuxi and foreign countries.
Wuxi has attached great significance to ecological conservation while driving its economy in the developmental fast lane.
Wuxi achieved fruitful results in implementing the strategy of innovation-driven growth by setting up 602 platforms of sci-tech innovation above provincial level, ranking second in Jiangsu province.
Wuxi Municipal Economic Development Zone held an industrial summit in Beijing on March 11.
Copyright © China Daily. All rights reserved.